🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Lululemon executive sells over $130k in company stock

Published 10/01/2024, 04:40 AM
© Reuters.
LULU
-

Nicole Neuburger, Chief Brand Officer of Lululemon Athletica Inc. (NASDAQ:LULU), has sold a portion of her company stock, according to a recent filing with the Securities and Exchange Commission. The transaction, which took place on September 26, involved the sale of 486 shares at a price of $269.59 per share, totaling approximately $131,020.

The sale has adjusted Neuburger's holdings in the company, leaving her with 6,198 shares of Lululemon's common stock following the transaction. The filing, signed on her behalf by Alex Grieve, Attorney-in-Fact, was dated September 27.

Lululemon Athletica, known for its high-end athletic apparel, has been a popular stock among investors, particularly as the brand continues to expand its global footprint and product offerings. Executive transactions such as these are closely watched by investors for insights into the company's internal confidence and potential future performance.

The details of the transaction are publicly available and provide transparency into the trading activities of Lululemon's executives. As with all such filings, the disclosed information serves as a record of changes in ownership by corporate insiders, offering investors a glimpse into the actions taken by those with in-depth knowledge of the company.

In other recent news, Lululemon Athletica Inc. reported a 7% increase in second-quarter total revenue, reaching $2.4 billion, and earnings per share (EPS) of $3.15, surpassing the expected $2.94. Despite these positive results, the company revised its fiscal year 2024 sales growth forecast from 11-12% to 8-9%. Analyst firms, such as Baird, Jefferies, Citi, and KeyBanc, have adjusted their outlooks and price targets accordingly. Baird maintained an Outperform rating and a price target of $350, expressing confidence in Lululemon's growth potential in the Asia-Pacific markets. Meanwhile, Jefferies maintained an Underperform rating with a price target of $220, citing potential weakening in the company's fundamentals. Citi maintained a Neutral stance, expressing concern over the effectiveness of Lululemon's strategy to rejuvenate U.S. sales, and KeyBanc lowered the price target to $350 but retained an Overweight rating, reflecting confidence in Lululemon's long-term fundamentals. These are the latest developments in the company's journey.

InvestingPro Insights

While Nicole Neuburger's recent stock sale provides a glimpse into insider activity, a broader look at Lululemon's financial metrics offers additional context for investors. According to InvestingPro data, Lululemon boasts a market capitalization of $33.32 billion, reflecting its significant presence in the athletic apparel market.

The company's financial health appears robust, with an InvestingPro Tip noting that Lululemon "holds more cash than debt on its balance sheet." This strong liquidity position is further supported by another tip indicating that "liquid assets exceed short term obligations," suggesting financial stability and flexibility for future growth initiatives.

Lululemon's performance metrics are also noteworthy. The company maintains impressive gross profit margins, as highlighted by an InvestingPro Tip. This is quantified by the gross profit margin of 58.54% for the last twelve months as of Q2 2025, underscoring the company's ability to maintain pricing power in a competitive market.

Despite these strengths, it's worth noting that the stock has experienced volatility, with an InvestingPro Tip mentioning that the "stock has taken a big hit over the last six months." This is reflected in the 6-month price total return of -28.32%. However, recent performance shows signs of recovery, with a significant 7.78% return over the last week.

For investors seeking a more comprehensive analysis, InvestingPro offers 11 additional tips for Lululemon, providing a deeper dive into the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.